Jingwei Cai

Jingwei Cai

Auto-generated profile, based on publicly available information

Jingwei Cai

Drug Metabolism and Pharmacokinetics, Genentech, United States

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
LSLulu Sun
Lulu Sun
CXCen Xie
Cen Xie
GWGuang Wang
Guang Wang
YWYue Wu
Yue Wu
QWQing Wu
Qing Wu
CJChangtao Jiang
Changtao Jiang

15 December 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CJChangtao Jiang
Changtao Jiang
CXCen Xie
Cen Xie
FLFei Li
Fei Li
LZLimin Zhang
Limin Zhang
RNRobert Nichols
Robert Nichols
FGFrank Gonzalez
Frank Gonzalez
Nonalcoholic fatty liver disease (NAFLD) is a major worldwide health problem. Recent studies suggest that the gut microbiota influences NAFLD pathogenesis. Here, a murine model of high-fat diet–induced (HFD-induced) NAFLD was used, and the effects of alterations in the gut microbiota on NAFLD were determined. Mice treated with antibiotics or tempol exhibited altered bile acid composition, with a notable increase in conjugated bile acid metabolites that inhibited intestinal farnesoid X receptor (FXR) signaling. Compared with control mice, animals with intestine-specific Fxr disruption had reduced hepatic triglyceride accumulation in response to a HFD. The decrease in hepatic triglyceride accumulation was mainly due to fewer circulating ceramides, which was in part the result of lower expression of ceramide synthesis genes. The reduction of ceramide levels in the ileum and serum in tempol- or antibiotic-treated mice fed a HFD resulted in downregulation of hepatic SREBP1C and decreased de novo lipogenesis. Administration of C16:0 ceramide to antibiotic-treated mice fed a HFD reversed hepatic steatosis. These studies demonstrate that inhibition of an intestinal FXR/ceramide axis mediates gut microbiota–associated NAFLD development, linking the microbiome, nuclear receptor signaling, and NAFLD. This work suggests that inhibition of intestinal FXR is a potential therapeutic target for NAFLD treatment.

22 January 2019 in Gut
Verified
Journal Article
Closed access
PDF file
VSVishal Singh
Vishal Singh
BYBeng San Yeoh
Beng San Yeoh
Rachel E WalkerRachel E Walker
Rachel E Walker
XXXia Xiao
Xia Xiao
PSPiu Saha
Piu Saha
MVMatam Vijay-Kumar
Matam Vijay-Kumar
Objective: Diets rich in fermentable fibres provide an array of health benefits; however, many patients with IBD report poor tolerance to fermentable fibre-rich foods. Intervention studies with dietary fibres in murine models of colonic inflammation have yielded conflicting results on whether fibres ameliorate or exacerbate IBD. Herein, we examined how replacing the insoluble fibre, cellulose, with the fermentable fibres, inulin or pectin, impacted murine colitis resulting from immune dysregulation via inhibition of interleukin (IL)-10 signalling and/or innate immune deficiency (Tlr5KO). Design: Mice were fed with diet containing either cellulose, inulin or pectin and subjected to weekly injections of an IL-10 receptor (αIL-10R) neutralising antibody. Colitis development was examined by serological, biochemical, histological and immunological parameters. Results: Inulin potentiated the severity of αIL10R-induced colitis, while pectin ameliorated the disease. Such exacerbation of colitis following inulin feeding was associated with enrichment of butyrate-producing bacteria and elevated levels of caecal butyrate. Blockade of butyrate production by either metronidazole or hops β-acids ameliorated colitis severity in inulin-fed mice, whereas augmenting caecal butyrate via tributyrin increased colitis severity in cellulose containing diet-fed mice. Elevated butyrate levels were associated with increased IL-1β activity, while inhibition of the NOD-like receptor protein 3 by genetic, pharmacologic or dietary means markedly reduced colitis. Conclusion: These results not only support the notion that fermentable fibres have the potential to ameliorate colitis but also caution that, in some contexts, prebiotic fibres can lead to gut dysbiosis and surfeit colonic butyrate that might exacerbate IBD.

1 December 2015 in Cell Metabolism
Verified
Journal Article
Closed access
VSVishal Singh
Vishal Singh
Chassaing BenoitChassaing Benoit
Chassaing Benoit
LZLimin Zhang
Limin Zhang
BYBeng San Yeoh
Beng San Yeoh
XXXia Xiao
Xia Xiao
MVMatam Vijay-Kumar
Matam Vijay-Kumar

25 October 2016 in mSystems
Verified
Journal Article
Open access
PDF file
LZLimin Zhang
Limin Zhang
CXCen Xie
Cen Xie
RNRobert Nichols
Robert Nichols
SCSiu Hung Joshua Chan
Siu Hung Joshua Chan
CJChangtao Jiang
Changtao Jiang
APAndrew Patterson
Andrew Patterson
The farnesoid X receptor (FXR) plays an important role in mediating the dialog between the host and gut microbiota, particularly through modulation of enterohepatic circulation of bile acids. Mounting evidence suggests that genetic ablation of Fxr in the gut or gut-restricted chemical antagonism of the FXR promotes beneficial health effects, including the prevention of nonalcoholic fatty liver disease in rodent models. However, questions remain unanswered, including whether modulation of FXR activity plays a role in shaping the gut microbiota community structure and function and what metabolic pathways of the gut microbiota contribute in an FXR-dependent manner to the host phenotype. In this report, new insights are gained into the metabolic contribution of the gut microbiota to the metabolic phenotypes, including establishing a link between FXR antagonism, bacterial bile salt hydrolase activity, and fermentation. Multiple approaches, including unique mouse models as well as metabolomics and genome-scale metabolic models, were employed to confirm these results.

1 February 2019 in Drug Metabolism and Disposition
Verified
Journal Article
Open access
PDF file
YTYuan Tian
Yuan Tian
JCJingwei Cai
Jingwei Cai
WGWei Gui
Wei Gui
RNRobert Nichols
Robert Nichols
IKImhoi Koo
Imhoi Koo
APAndrew Patterson
Andrew Patterson
Intestinal bacteria play an important role in bile acid metabolism and in the regulation of multiple host metabolic pathways (e.g., lipid and glucose homeostasis) through modulation of intestinal farnesoid X receptor (FXR) activity. Here, we examined the effect of berberine (BBR), a natural plant alkaloid, on intestinal bacteria using in vitro and in vivo models. In vivo, the metabolomic response and changes in mouse intestinal bacterial communities treated with BBR (100 mg/kg) for 5 days were assessed using NMR- and mass spectrometry-based metabolomics coupled with multivariate data analysis. Short-term BBR exposure altered intestinal bacteria by reducing the Clostridium cluster XIVa and IV and their bile salt hydrolase (BSH) activity, which resulted in the accumulation of taurocholic acid (TCA). The accumulation of TCA was associated with activation of intestinal FXR, which can mediate bile acid, lipid, and glucose metabolism. In vitro, isolated mouse cecal bacteria were incubated with three doses of BBR (0.1, 1, and 10 mg/ml) for 4 h in an anaerobic chamber. NMR-based metabolomics combined with flow cytometry was used to evaluate the direct physiologic and metabolic impact of BBR on the bacteria. In vitro, BBR exposure not only altered bacterial physiology, but also changed the bacterial community composition and function, especially reducing BSH expressing bacteria like Clostridium spp. These data suggest that BBR directly impacts bacteria to alter bile acid metabolism and activate FXR signaling. These data provide new insights into the link between intestinal bacteria, nuclear receptor signaling, and xenobiotics.